https://hr.prisysbiotech.com/ Ne - Ljudski Primat Istraživanje Platforma & HRV | PRISYS Biotehnologija https://hr.prisysbiotech.com/uploads/39406/logo.png https://hr.prisysbiotech.com/translation-research/ Istraživanje prijevoda https://hr.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://hr.prisysbiotech.com/nhp-pharmacology/ Farmakologija NHP https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/safety-evaluation/ Procjena sigurnosti https://hr.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://hr.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://hr.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://hr.prisysbiotech.com/biosafety-research/ Biosafety Research https://hr.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://hr.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://hr.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://hr.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://hr.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://hr.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://hr.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://hr.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://hr.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://hr.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://hr.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://hr.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://hr.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://hr.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://hr.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://hr.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://hr.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://hr.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://hr.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://hr.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://hr.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://hr.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://hr.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://hr.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://hr.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://hr.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://hr.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://hr.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://hr.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://hr.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://hr.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://hr.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://hr.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://hr.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://hr.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://hr.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://hr.prisysbiotech.com/pk-pd-adme/adme.html ADME https://hr.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://hr.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://hr.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://hr.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://hr.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://hr.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://hr.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://hr.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://hr.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://hr.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://hr.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://hr.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://hr.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://hr.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://hr.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://hr.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://hr.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://hr.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://hr.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://hr.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://hr.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://hr.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://hr.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://hr.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://hr.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://hr.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://hr.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://hr.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://hr.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://hr.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://hr.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://hr.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://hr.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://hr.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://hr.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://hr.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://hr.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://hr.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://hr.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://hr.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://hr.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://hr.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://hr.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://hr.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://hr.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://hr.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://hr.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://hr.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://hr.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://hr.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://hr.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://hr.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://hr.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://hr.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://hr.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://hr.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://hr.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://hr.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://hr.prisysbiotech.com/translation-research/clinical-imaging.html Klinička slika https://hr.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klinička slika https://hr.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://hr.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://hr.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://hr.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://hr.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://hr.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://hr.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://hr.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://hr.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://hr.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://hr.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://hr.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://hr.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://hr.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://hr.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://hr.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://hr.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://hr.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Model dijabetes melitusa tipa 2 https://hr.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Model dijabetes melitusa tipa 2 https://hr.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://hr.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://hr.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://hr.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://hr.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://hr.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://hr.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://hr.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://hr.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://hr.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://hr.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://hr.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://hr.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://hr.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://hr.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://hr.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://hr.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://hr.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://hr.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://hr.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://hr.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://hr.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://hr.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://hr.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://hr.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://hr.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://hr.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://hr.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://hr.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://hr.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://hr.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://hr.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://hr.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://hr.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://hr.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://hr.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://hr.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://hr.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://hr.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://hr.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://hr.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://hr.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://hr.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://hr.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://hr.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://hr.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://hr.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://hr.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://hr.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://hr.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://hr.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://hr.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://hr.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://hr.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003098771923968.html Molekularno oslikavanje u NHP modelima za translacijski razvoj lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://hr.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968060563366912.html Webinar NHP BehaviorAtlas|3D NHP praćenje ponašanja za razvoj lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://hr.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724204033991680.html Rekapitulacija za 2025.: Kako Prisys redefinira translacijsku pouzdanost u NHP istraživanju https://hr.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://hr.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17554361248113665.html NHP - Farmakologija i farmakodinamičke usluge|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://hr.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530747009442816.html Upoznajte Prisys Biotech na nadolazećem EU Roadshow: Rujan 2025 https://hr.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://hr.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17447079527638016.html Prisys Biotech-2025. Pregled srednje godine https://hr.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://hr.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245407385003008.html Upoznajte Prisys u predstojećem američkom roadshowu u ožujku 2025 https://hr.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://hr.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84034368.html Godišnje izvješće PRISYS-a za 2024.: Unaprjeđenje NHP modela i pretklinička istraživanja https://hr.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://hr.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77718195.html Prisys Biotech 2024 Q2 Newsletter - Poboljšano predkliničko istraživanje i razvoj za terapiju središnjeg živčanog sustava s PRISYS križnoreaktivnim modelima https://hr.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://hr.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028055085786112.html Zašto životinjski modeli uspijevaju ili ne uspijevaju u razvoju lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021133677306880.html Kvantitativni PET ciljani angažman u NHP-ima za lijekove za CNS https://hr.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://hr.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015089986642944.html Od videa do podataka: 3D AI praćenje za NHP ponašanje https://hr.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://hr.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015182164780032.html PET slikanje biodistribucije kod primata koji nisu-ljudi https://hr.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://hr.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003098544415744.html PBPK vs. Kompartmentalni modeli: zašto je PBPK važan https://hr.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://hr.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993025351345152.html Rekapitulacija webinara: Unaprjeđenje translacijskog NHP istraživanja kroz digitalno bihevioralno fenotipiziranje https://hr.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://hr.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990293660296192.html PK biomarkeri u pretkliničkom razvoju lijekova|Izloženost – odgovor & PK/PD https://hr.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://hr.prisysbiotech.com/news/behavior-in-rhesus-17983368521491456.html Spontano samo{0}}ozljeđujuće ponašanje kod Rhesus Macaques: Translacijski NHP model za razvoj neuropsihijatrijskih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://hr.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983367544300544.html MIDD i NHP modeli učinkovitosti u razvoju translacijskih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://hr.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973368593982464.html AI-3D NHP analiza ponašanja|Fenotipizacija ponašanja bez markera https://hr.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://hr.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973368697758720.html Globalni webinar|Kvantificiranje složenih NHP ponašanja: predstavljamo NHP BehaviorAtlas za visoko{0}}vjernost 3D fenotipa ponašanja https://hr.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://hr.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968060471731200.html AI-Powered NHP analiza ponašanja za pretklinički razvoj lijekova|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://hr.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973369305981952.html Kada uvesti NHP studije u razvoj autoimunih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://hr.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973388221441024.html NHP IBD modeli: Što nas kronični enterokolitis u Rhesus Macaques uči o translacijskoj upali crijeva https://hr.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://hr.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973368342733824.html MRI-Vođena AAV isporuka u NHP modelima mozga za CNS gensku terapiju https://hr.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://hr.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973368761443328.html Zašto su lijekovi pozitivne kontrole važni u modelima autoimunih bolesti|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://hr.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973368604861440.html Osnovni ADA probir kod ispranih-majmuna za pretkliničke biološke studije https://hr.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://hr.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968060426511360.html Mehanizmi boli: UVB model opeklina od sunca vitalan je translacijski alat https://hr.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://hr.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968060700566528.html NHP modeli majčine prehrane s-mastima i programiranja pretilosti u djetinjstvu https://hr.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://hr.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17937796190970880.html Interpretacija kliničke patologije kod pasa i neljudskih primata u pretkliničkim studijama https://hr.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://hr.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17937796692452352.html Molecular Imaging Biomarkers: Unapređenje translacijskih istraživanja i razvoja lijekova https://hr.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://hr.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17937806448780288.html Što je nelinearna farmakokinetika? Mehanizmi, karakteristike i implikacije za razvoj lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://hr.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17937796269548544.html Zašto je NHP molekularno snimanje kritično za translacijske PET studije https://hr.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://hr.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17937795987399680.html Što je molekularno oslikavanje i zašto je važno u razvoju lijekova? https://hr.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://hr.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17937796210058240.html Studije biodistribucije radionuklida NHP: Molekularno oslikavanje za translacijski razvoj lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://hr.prisysbiotech.com/news/nhp-heart-failure-model-17937796496532480.html NHP model zatajenja srca podupire translacijska istraživanja genske terapije obnove telomera https://hr.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://hr.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17937805914285056.html Kako DSA i CTA imaging poboljšavaju procjenu sigurnosti kardiovaskularnih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://hr.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17937796234208256.html NHP model tromboze arteriovenskog šanta u Cynomolgus majmuna za translacijsku procjenu antitrombotičkih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://hr.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888310353634304.html Farmakokinetički podaci kao translacijski biomarker https://hr.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://hr.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888310355305472.html Ne-modeli plućne fibroze kod primata: unaprjeđenje točnosti translacije u razvoju respiratornih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://hr.prisysbiotech.com/news/nhp-models-translational-drug-development-17888310126420992.html Zašto razvoj lijekova sve više ovisi o NHP modelima|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://hr.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888312161674240.html Farmakokinetički podaci kao farmakodinamički biomarker: Unapređenje razvoja translacijskih lijekova kroz kvantitativnu farmakologiju https://hr.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://hr.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17853904544228352.html Ne-GLP farmakološke studije za podnošenje propisima: Integritet podataka i laboratorijski zahtjevi https://hr.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://hr.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17853904552043520.html Strateški dizajn nekliničkih farmakokinetičkih studija: od ADME profiliranja do translacijskog odlučivanja- https://hr.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://hr.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17853904450708480.html NHP AV-model tromboze šanta za procjenu sigurnosti lijekova|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://hr.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17853904117998592.html Što je nelinearna farmakokinetika? Mehanizmi i translacijska PK evaluacija|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://hr.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17853904349012992.html Prisys Biotech podržava IND odobrenje UX-GIP001 od strane FDA i CDE|Platforma za isporuku NHP CNS https://img01.v15cdn.com/gallery/4x3/157.webp https://hr.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17853904107004928.html In vivo praćenje imunoloških stanica i razvoj PET tragača u NHP modelima|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://hr.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17853904445285376.html PET slika transportera dopamina u NHP modelima|Slike CNS-a|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://hr.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17853904038274048.html PET/CT biodistribucija u NHP modelima za isporuku lijekova u CNS|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://hr.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17853904249922560.html Velika-platforma za radiooznačavanje životinja i in vivo slikovna platforma za razvoj translacijskih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://hr.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17853904150832128.html Zašto se razvoj lijekova sve više oslanja na NHP modele: Bitna uloga primata u translacijskoj medicini|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://hr.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17853903988024320.html IPF izazovi i rješenja razvoja lijekova|NHP modeli s CT slikom i PFT https://hr.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://hr.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17853904007504896.html AI NHP 3D sustav za analizu ponašanja bez markera za pretklinička istraživanja https://hr.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://hr.prisysbiotech.com/news/evaluating-dmpk-properties-17853904131662848.html Procjena DMPK svojstava spojeva kandidata u ranom otkrivanju lijekova|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://hr.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17853904177751040.html MRI-Vođena isporuka CNS-a u NHP modelima|Translacijska IMRI & CED platforma https://hr.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://hr.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17853904123339776.html NHP studije biodistribucije CNS-a|Intratekalna dostava RNA|PRISYS biotehnologija https://hr.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://hr.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17853904279118848.html Translacijski PK/PD okvir: Predviđanje doze od Cynomolgus majmuna do ljudi|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://hr.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724204100543488.html Kada bol postane sjećanje: emocionalni pokretači kronične boli i prednost NHP modela|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://hr.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724203993244672.html Procjena boli s više-krajnjih točaka: budućnost razvoja analgetika https://hr.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://hr.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724204036662272.html Zašto toliko mnogo analgetika ne uspije u pretkliničkim ispitivanjima? Odgovor leži u načinu na koji mjerimo bol https://hr.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://hr.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724220653560832.html Dizajn vremenske točke uzorkovanja krvi u farmakokinetičkim (PK) studijama|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://hr.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724220623004672.html PK statistika: parametri ne{0}}kompartmentalne analize (NCA) i pretkliničke primjene https://hr.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://hr.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724204042314752.html Zašto su modeli ne-ljudskih primata kritični za CNS oligonukleotidnu terapiju https://hr.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://hr.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724204079260672.html Metabolizam mokraćne kiseline kod ljudi u odnosu na majmune: Translacijske implikacije za razvoj lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://hr.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724203973305344.html Model fibroze jetre nepovezan s -ljudskim primatom MASH-|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://hr.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724204087583744.html Zašto je IMRI-navođena isporuka lijekova u mozak ključna za precizno ciljanje u NHP studijama https://hr.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://hr.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674563549144064.html NHP 3D sustav za analizu ponašanja bez markera-pokretan umjetnom inteligencijom|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://hr.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674563612419072.html LPS-model NHP inducirane akutne upale pluća (ALI)|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://hr.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674563782697984.html HDM+SEB-Model induciranog atopijskog dermatitisa (AtD) kod Cynomolgus majmuna https://hr.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://hr.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674563698287616.html Objašnjenje modela PK s jednim- do više-odjeljaka|Farmakokinetika NHP|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://hr.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674563682673664.html Kako odabrati pouzdanu pretkliničku CRO|Ključni kriteriji za biotehnološke tvrtke|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://hr.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674563509445632.html Translacijska CAR{0}}T evaluacija: In Vitro ekspertiza i podrška NHP studiji — Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://hr.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674563578831872.html Zašto više od 90% kandidata za lijekove za CNS ne uspije u kliničkim ispitivanjima? https://hr.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://hr.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674563779126272.html Pretklinički modeli Parkinsonove bolesti: Vodič za odabir neurotoksinskih, genetskih i NHP modela|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://hr.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674563628016640.html Visoko{0}}precizna isporuka lijekova i NHP-translacijske platforme vođene umjetnom inteligencijom https://hr.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://hr.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625071167300608.html NHP imunološki modeli vođeni Th17|Translacijska autoimuna istraživanja u Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://hr.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625071344739328.html Sustav NHP BehaviorAtlas® temeljen na-AI|3D platforma za analizu ponašanja|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://hr.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625071330157568.html Predložak RFP-a za NHP studije|Ubrzajte učinkovitost pretkliničkog istraživanja https://hr.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://hr.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625071101551616.html Model boli uzrokovane hladnom alodinijom u Cynomolgus majmuna|Prisys Biotechnologies https://hr.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://hr.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625071314805760.html MRI-Platforma za intracerebralnu isporuku lijekova|Prisys Biotech istraživanje CNS-a https://hr.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://hr.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625071544968192.html NHP modeli respiratornih bolesti i platforma za dostavu lijekova u dišnim putovima|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://hr.prisysbiotech.com/news/nhp-renal-biopsy-17625071590286336.html NHP platforma za biopsiju bubrega i modeli bolesti bubrega|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://hr.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625071406982144.html PK studije i ciljana isporuka lijekova|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://hr.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625071242732544.html Platforma za NHP istraživanje i-analizu ponašanja temeljena na AI-ju Prisys Biotechnologies https://hr.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://hr.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625071107400704.html Tehnologija prijenosa-u-mozak (N2B) za istraživanje CNS-a|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://hr.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625071069258752.html SHR-2004: Proboj u prevenciji VTE za pacijentice s rakom jajnika – Prisys Biotech Priča o uspjehu https://hr.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://hr.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538118219211776.html Modeli Cynomolgus i Rhesus majmuna|Prisys Biotech Preclinical CRO https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530746732635136.html Idiopatska plućna fibroza (IPF) NHP model|Prisys Biotech Pretklinički CRO https://hr.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://hr.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530747022599168.html Studije biodistribucije Cynomolgus majmuna|Prisys Biotech Preclinical CRO https://hr.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://hr.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530747028284416.html Prisys Biotech NHP modeli za hematologiju i istraživanje moždanog udara https://hr.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://hr.prisysbiotech.com/news/the-importance-of-administration-volume-17530746716955648.html Važnost volumena administracije u pretkliničkim studijama|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://hr.prisysbiotech.com/news/brain-targeted-drug-delivery-17530746686350336.html Mozak - ciljana isporuka lijeka|Prisys Biotech Pretkliničko istraživanje NHP -a https://hr.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://hr.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530747304043520.html ADC razvoj lijekova|Translacijski PK/PD okvir u pretkliničkim NHP studijama https://hr.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://hr.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17495611489575936.html NHP modeli boli za translacijsko otkrivanje droga|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://hr.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17495611446715392.html Serum vs. Plazma: Odabir optimalne matrice za pretkliničku bioanalizu https://hr.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://hr.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17495611413455872.html Pretkliničke smjernice za doziranje: IV i PO volumen, PH i osmolarnost za točnu PK kod NHP i drugih vrsta https://hr.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://hr.prisysbiotech.com/news/nhp-copd-model-17495611393795072.html Vrhunski istraživački modeli KOPB -a i izvrsnost respiratorne platforme od prisys https://hr.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://hr.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17495611323360256.html Model akutnog krvarenja NHP -a: Ključni alat za ubrzanje nove hematološke razvoje lijekova https://hr.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://hr.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17495611473617920.html Pruritus Research: Prisys Biotech-ov IL-31-inducirani NHP model za procjenu terapije protiv borbe https://hr.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://hr.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17447080188847104.html Vodič za procjenu anti{0}}protutijela na lijekove (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17447079629628416.html Respiratorne terapije: Integrirana NHP platforma Prisys Biotech za pretklinička istraživanja https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17447118384587776.html NHP Modeli boli: Ubrzavanje razvoja analgetskih lijekova u Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://hr.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17447118512808960.html Platforme NHP modela za podršku razvoju lijekova kod složenih bolesti https://hr.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://hr.prisysbiotech.com/news/key-considerations-for-dosing-volume-17447118372398080.html Ključna razmatranja za volumen doziranja, PH i formulaciju u životinjskim modelima https://hr.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://hr.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17447079481402368.html Projektirani egzosomi: Revolucioniranje isporuke lijekova za poremećaje središnjeg živčanog sustava – pretklinički uvidi Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://hr.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17447079783064576.html Vodeći principi za odabir životinjskih vrsta u toksikološkim studijama lijekova nukleinskih kiselina https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17447079667950592.html DSA i IMRI tvrtke Prisys Biotech za hematološke, vaskularne i studije bubrežnih bolesti https://hr.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://hr.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17447079445062656.html Modeli boli Cynomolgus Monkey: Poticanje translacijskih istraživanja za revolucionarnu terapiju ionskim kanalima https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17447118434182144.html Istraživanje atopijskog dermatitisa: Prisys Biotech-ov model primata (NHP) primat (NHP) https://hr.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://hr.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17447079357654016.html Prisis Biotech-ov NHP atopijski dermatitis model za razvoj anti-pruritskih lijekova https://hr.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://hr.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17387441465582592.html Dizajniranje studija na životinjama: ključna razmatranja za uspjeh pretkliničkog istraživanja https://img01.v15cdn.com/gallery/4x3/300.webp https://hr.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17387440860226560.html Atopijski dermatitis: Kako modeli majmuna Cynomolgus unaprijed precizno terapeutike https://hr.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://hr.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17387440773440512.html Istraživanje astme: Zašto su modeli primata koji nisu-ljudi ključni za razvoj novih lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17387440887768064.html Razumijevanje farmakokinetike antisense oligonukleotida (ASO): ključni čimbenici u apsorpciji i distribuciji https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17387441089815552.html NHP studije inhalacije za biološke lijekove: PRISYS-ove specijalizirane pretkliničke CRO usluge https://img01.v15cdn.com/gallery/4x3/300.webp https://hr.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17387440954614784.html Napredne pretkliničke studije inhalacije: Tehničke mogućnosti i stručnost u Prisys Biotechu https://img01.v15cdn.com/gallery/4x3/300.webp https://hr.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17387440754828288.html Razumijevanje farmakokinetike (PK): Ključni parametri i primjene u razvoju lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://hr.prisysbiotech.com/news/intracerebroventricular-icv-injection-17387440933561344.html Intracerebroventrikularna (ICV) injekcija: Precizna dostava u CNS za pretklinička istraživanja https://hr.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://hr.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17387440863454208.html Intracerebralna (ICM) injekcija: Precizno ciljanje za terapiju CNS-a – Pretklinička razmatranja https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17387441099449344.html Intratekalna (IT) injekcija: izravan put dostave u središnji živčani sustav za napredne terapije – pretklinička razmatranja https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17387440890192896.html Unapređenje istraživanja Parkinsonove bolesti s NHP modelom https://img01.v15cdn.com/gallery/4x3/300.webp https://hr.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17387524414465024.html Predkliničke PK/PD studije i NHP modeli za razvoj lijekova|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://hr.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17302651867620352.html Ciljanje na interleukin-31 (IL-31): Nova granica u razvoju lijekova za autoimune bolesti – Prisys Biotech NHP modeli za pretklinička istraživanja https://hr.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://hr.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17301645073179648.html Neklinička procjena imunotoksičnosti: strategija, ključna razmatranja i odabir metode https://img01.v15cdn.com/gallery/4x3/232.webp https://hr.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17301644801516544.html Mikrobno testiranje i njegov utjecaj na ne-ljudske primate u pretkliničkim studijama DMPK https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17301644877112320.html Cynomolgus Model endometrioze majmuna za napredovanje terapijskih istraživanja https://hr.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://hr.prisysbiotech.com/news/membranous-nephropathy-model-17301644650685440.html Unapređenje razvoja lijeka za membransku nefropatiju (MN): Platforma modela Cynomolgus majmuna tvrtke Prisys Biotech https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17301644892136448.html Farmakokinetika inhaliranih lijekova: promjena paradigme od sistemske do plućne izloženosti https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/animal-models-for-womens-health-17301644700509184.html Prisys Biotech: Životinjski modeli za terapiju zdravlja žena https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17301645032956928.html Svjetski dan pretilosti|Prisys Biotech NHP Metabolički modeli: Uključivanje razvoja terapija protiv pretilosti sljedeće generacije https://hr.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://hr.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17301644782183424.html Model psorijaze za Cynomolgus Monkey Cynomolgus Monkey: Unaprezanje procjene pretkliničke farmakodinamike https://hr.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://hr.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17301644720579584.html Integracija farmakokinetike i farmakodinamike u razvoju lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://hr.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888310191776768.html Na-webinar na zahtjev|Precizni most: MRI-vođeni CED i translabilni NHP modeli za isporuku lijekova za CNS https://hr.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://hr.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17301644928885760.html Što Proof of Concept (PoC) u razvoju lijekova stvarno potvrđuje? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17301644604351488.html Modeli životinja|Izazovi i primjene u razvoju modela boli https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17301644850373632.html Neklinička farmakodinamička istraživanja https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245407730672640.html Odabir idealnog ne{0}}ljudskog primata za toksikološke studije: Cynomolgus Macaque, Rhesus Macaque i Marmoset https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81159829.html Ciljana terapija za Parkinsonovu bolest: napredak u-Vođenoj transplantaciji matičnih stanica-MRI-u stvarnom vremenu https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17301644657239040.html Sistemski eritematozni lupus (SLE) i uloga životinjskih modela u terapijskom razvoju https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17301644734030848.html Model primata koji nije ljudski za reumatoidni artritis (RA) https://hr.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://hr.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17301644649833472.html Stereotaktički instrumenti životinjskog mozga temeljeni na 3D koordinatnim sustavima https://hr.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://hr.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17301645012542464.html Životinjski modeli za testiranje in vivo (1): uspostavljanje i klasifikacija https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84034357.html Istraživanje mogućih puteva za ulazak bioloških lijekova u mozak https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84034358.html Unapređenje istraživanja reumatoidnog artritisa (RA) s modelima primata koji nisu ljudi https://hr.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://hr.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84034951.html Istraživanje učinkovitosti lijekova za atopijski dermatitis na životinjskim modelima https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84034361.html Kritična uloga životinjskih modela u istraživanju ljudskih bolesti https://hr.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://hr.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84034362.html Model majmuna s nedostatkom gena Parkin otkriva nove mehanizme i terapeutske ciljeve za Parkinsonovu bolest https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84034360.html Neklinički vodič za razvoj lijekova: Studije akutne, subakutne, subkronične i kronične opće toksičnosti https://hr.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://hr.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84034359.html Inovativna dostava lijeka od nosa do mozga (N2B): zaobilaženje krvno-moždane barijere https://hr.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://hr.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84034407.html Mogućnosti i izazovi mini svinja kao nekliničke velike životinjske vrste https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83039060.html Strategije davanja lijekova za bolesti mozga https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83043738.html Intraoperativna MRI navigacija-u stvarnom vremenu: Potpora FDA odobrenju prve genske terapije za nedostatak AADC https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83034314.html Studije očne toksičnosti kapi za oči: izloženost lijeku i procjena sigurnosti https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82719568.html Prisys Biotech uspostavlja model psorijaze Cynomolgus Monkey kako bi ubrzao razvoj lijeka https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82719565.html Sveobuhvatni modeli primata koji nisu-ljudi za istraživanje bubrežnih bolesti, Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82719560.html Sveobuhvatna predklinička procjena sigurnosti konjugata-lijekova protutijela (ADC) u ne-ljudskih primata https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82719559.html Farmakokinetička procjena konjugata-lijekova protutijela (ADC) u ne-ljudskih primata https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82719558.html Farmakodinamička procjena ADC-a https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82719562.html Razumijevanje DMPK ADC lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82719566.html Napredak u razvoju lijekova nukleinskih kiselina i istraživačke sposobnosti Prisys Biotecha https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395262.html Napredak u plućnim sustavima dostave mRNA i inovativnim uslugama tvrtke Prisys biotech https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82719577.html Zašto je Nobelova nagrada za fiziologiju ili medicinu 2024. dodijeljena ovoj dvojici znanstvenika koji su proučavali MicroRNA? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82719563.html Farmakokinetička (PK) razmatranja za lijekove za središnji živčani sustav (CNS). https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656489.html Napredak u istraživanju CNS-a: Prisys Biotechov MRI-kompatibilni sustav injekcije u mozak i CED tehnologija https://hr.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://hr.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81159831.html Unapređenje terapijskih inovacija krvarenja i zgrušavanja s modelom MCAO majmuna Cynomolgus https://hr.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://hr.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81159830.html DMPK procjena lijekova za središnji živčani sustav (CNS). https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/animal-models-of-human-diseases-81159820.html Životinjski modeli ljudskih bolesti https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81159826.html Inovacije u procjeni boli:-analiza ponašanja vođena umjetnom inteligencijom https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/china-experimental-monkey-industry-81159822.html Povijest, trenutni status, izazovi i mogućnosti kineske industrije eksperimentalnih majmuna https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/human-disease-animal-models-81159821.html Životinjski modeli ljudskih bolesti: ključni alat za unaprjeđenje biomedicinskih istraživanja https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81159823.html Važnost pretkliničke farmakodinamike u razvoju lijekova|Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://hr.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81159825.html Intranazalna primjena u studijama na životinjama https://hr.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://hr.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79419862.html Revolucioniranje razvoja lijekova za CNS: PRISYS Biotech predstavlja IMRI tehnologiju https://hr.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://hr.prisysbiotech.com/news/convection-enhanced-delivery-81159819.html Unaprjeđenje precizne medicine: tehnologija-poboljšane isporuke konvekcije (CED) tvrtke Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://hr.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81159824.html Model kronične bubrežne bolesti Cynomolgus majmuna (CKD) tvrtke Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://hr.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79537723.html Neklinička procjena sigurnosti okularne primjene lijeka pomoću Cynomolgus Macaques https://hr.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://hr.prisysbiotech.com/news/compartment-pk-model-81159828.html Razumijevanje modela odjeljaka i ne-odjeljaka u farmakokinetici https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81159818.html Napredne tehnike isporuke CNS-a u Cynomolgus majmuna: Ubrzavanje razvoja oligonukleotidnog lijeka https://hr.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://hr.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79537691.html Smanjenje upotrebe nehumanih primata u nekliničkim procjenama sigurnosti: perspektive FDA i industrije https://hr.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://hr.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79537726.html LCMS pretklinička bioanaliza lijekova za gensku terapiju temeljenih na LNP- https://hr.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://hr.prisysbiotech.com/news/mrna-based-therapies-past-79537721.html Terapije-temeljene na MRNA: prošlost https://hr.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://hr.prisysbiotech.com/news/pk-strategies-of-pdc-79537689.html Strategije farmakokinetičke studije peptidnih-konjugata lijekova (PDC) https://hr.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://hr.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79537699.html Uloga AAV u genskoj terapiji: imunološki odgovori i toksičnost https://hr.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://hr.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79537708.html Optimizirane nekliničke strategije procjene imunogenosti https://hr.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://hr.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79537722.html Farmakodinamička (PD) evaluacija genske terapije https://hr.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://hr.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537717.html Farmakokinetika i bioanaliza oligonukleotidnih lijekova-(1) https://hr.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://hr.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537727.html Farmakokinetika i bioanaliza oligonukleotidnih lijekova: karakteristike apsorpcije i farmakokinetike plazme (PK) https://hr.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://hr.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79537713.html Čimbenici koje treba uzeti u obzir za imunogenost oligonukleotidnih lijekova https://hr.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://hr.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79537731.html MRNA: snažan i svestran alat za borbu protiv bolesti-Prisys-Biotech https://hr.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://hr.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79537709.html Kineski znanstvenici nude nove strategije za poništavanje temeljnih simptoma Parkinsonove bolesti https://hr.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://hr.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79537703.html Prisys Biotehnologija: Nove lipidne nanočestice za isporuku MRNA u primata https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79537714.html Važnost translacijskih medicinskih istraživanja od osnovnih istraživanja do kliničkih studija https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79537725.html Glavni čimbenici uzeti u obzir u WOE analizi https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79537707.html Kako dostaviti biološke lijekove u mozak? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79537704.html Kako se lijekovi kreću i mijenjaju u našim tijelima: Kratki uvod u farmakokinetiku https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79537706.html Kako brže i sigurnije razviti nove lijekove: vodič kroz pretkliničke studije DMPK https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79537715.html Smjernice za skupni smještaj laboratorijskih majmuna https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79537695.html Vitalna uloga pokusnih majmuna u unapređenju znanstvenog istraživanja https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79537719.html Razumijevanje Macaca Fascicularis (Cynomolgus majmun): ključne karakteristike i doprinosi biomedicinskom istraživanju https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79537718.html Revolucioniranje liječenja metaboličkih bolesti: napredak i izazovi u razvoju peptidnih lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79537693.html Kako procijeniti sigurnost proizvoda za kožu prije kliničkih ispitivanja? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79537716.html Značajna uloga pokusnih majmuna u razvoju inovativnih lijekova: pogled iznutra na poslovanje https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79537729.html Toksičnost jetre kao ključna briga za SiRNA lijekove: Sveobuhvatna analiza Ciljna specifičnost: dvosjekli mač SiRNA https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79537724.html Unapređenje SiRNA terapije: prevladavanje izazova u razvoju lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79537692.html Mogućnosti primjene genskih lijekova na bazi lipidnih nanočestica https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79537710.html Ključne točke u dizajniranju strategija za ne-kliničke studije na mladim životinjama https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79537697.html Uvid u senzorne i bihevioralne osobine primata koji nisu{0}}ljudi (NHP) https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79537720.html Pitanja i odgovori o evaluaciji nekliničke studije https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/significance-principles-and-requirements-of-79537732.html Značaj, načela i zahtjevi sigurnosnog farmakološkog istraživanja https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79537702.html Kako procijeniti pretkliničku farmakološku učinkovitost? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79537694.html Razmišljanja o ne-kliničkim farmakološkim studijama i evaluaciji terapijskih lijekova za ne-alkoholni steatohepatitis (NASH) https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79537687.html Unapređenje CNS i CGT istraživanja: Prisys Biotechnologies https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79537690.html Smjernice za prikupljanje cerebrospinalne tekućine ne-ljudskih primata https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79537700.html Razmatranja za tumačenje kliničkih patoloških podataka kod ne-ljudskih primata (NHP) i očnjaka https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79537683.html ​​​​​​​Integriranje evaluacije sigurnosti CNS-a u opće toksikološke studije https://hr.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://hr.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79537696.html Kako provesti pretkliničku farmakološku/toksikološku procjenu ADC-ova? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79537705.html ADME Insights For Oligonucleotide Drugs (1) - Apsorpcija, Distribucija https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79537701.html ADME Insights For Oligonucleotide Drugs (2) - Metabolizam i izlučivanje https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79537678.html Pretkliničke studije na životinjama (1) - Životinjske vrste https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79537682.html Izazovi i strategije tumačenja kliničkih patoloških podataka u pretkliničkim studijama pasa i ne-ljudskih primata https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79537730.html Pretkliničke studije na životinjama (2) - Putevi i količine primjene https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/mrna-based-therapies-present-79538693.html Terapije-temeljene na MRNA: Prisutno https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79537728.html Terapije-temeljene na MRNA: budućnost i izazovi https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79537711.html Kratki uvod o biološkoj analizi genske terapije https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79420107.html Majmun Cynomolgus u istraživanju oftalmoloških lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79419863.html Translacijske i unakrsno-reaktivne studije s Prisysovim NHP modelima imunologije i upale https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79199857.html Ne{0}}naivni NHP-ovi u pretkliničkim ispitivanjima: isplativo-rješenje tvrtke Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/nhp-asthma-model-79199855.html NHP model astme: Osnaživanje pretkliničkih studija učinkovitosti lijekova s ​​Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79199859.html Unaprjeđenje istraživanja imunologije i upale s modelima Cynomolgus Macaques - Prisys Biotechnologies https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79199854.html Izravna dostava oligonukleotidnih lijekova u CNS i uobičajene histopatološke promjene https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79199860.html Model intra-cerebrovaskularnog moždanog udara (ICH) tvrtke Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75167535.html Ne-kliničko istraživanje farmakodinamike: bitan aspekt u razvoju lijekova SiRNA https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77718196.html MRI-Vođeni sustav precizne lokalizacije središnjeg živčanog sustava velikih životinja i sustav isporuke smjestio se u Prisys Biotech https://hr.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://hr.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77062606.html Inovativna rješenja za unaprjeđenje respiratorne terapije https://hr.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://hr.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74799302.html Prisys: Unaprjeđenje pokusa na životinjama kroz studije Cynomolgus Macaque https://hr.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://hr.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76182417.html Prisys dobiva potpunu akreditaciju od strane AAALAC International: prekretnica u osiguravanju visokih standarda skrbi za laboratorijske životinje. https://hr.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://hr.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74675917.html Unapređenje terapije nukleinskim kiselinama kroz-suvremene modele Prisys Biotech nehumanih primata https://hr.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://hr.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74172037.html Revolucioniranje isporuke lijekova za CNS: Prisys i obećanje intratekalne injekcije https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75167537.html Prisys Biotech 2024 Q1 Newsletter - vaš pouzdani stručnjak za istraživanje neljudskih primata https://hr.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://hr.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73543336.html Kako ultrazvukom-vođena biopsija jetre poboljšava-temeljena istraživanja makaka https://hr.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://hr.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73543335.html Smjernice za cjeloživotno korištenje neljudskih primata u biomedicinskim istraživanjima: Prisysova biotehnološka perspektiva https://hr.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://hr.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73021805.html Primati koji nisu{0}}ljudi: Kratak uvod u njihove biološke značajke https://hr.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://hr.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72678331.html Prikaz izložbe|Prisys Biotech blista na godišnjem sastanku Američkog društva za neuroznanost (SfN 2023.) https://hr.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://hr.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321918.html Upoznajte Prisys Biotech na godišnjem sastanku Društva za neuroznanost (SfN 2023.) https://hr.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://hr.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321919.html Svjetski dan moždanog udara|Fokus na životinjskim modelima i farmakologiji ishemijskog moždanog udara https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321915.html Prisys Biotech vas poziva da prisustvujete godišnjem sastanku SAPA-China 2023. https://hr.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://hr.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321920.html Svjetski dan Alzheimerove bolesti|Izazovi i rješenja za razvoj lijekova za AD https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321917.html Životinjski model Cynomolgus Macaque tvrtke Prisys Biotech pomaže u razvoju novih lijekova protiv zgrušavanja krvi https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71067832.html Prisys: Pružanje visoko{0}}kvalitetne usluge pokusa na životinjama za novo anti{1}}antitijelo koagulacijskog faktora XI BJTJ-1837 https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71067833.html Metoda za utvrđivanje modela hipertrigliceridemije majmuna Cynomolgus i njezina primjena https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71067835.html Farmakologija: glavni parametri i značaj farmakokinetike (PK) https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71067829.html Pretklinička farmakološka evaluacija onkolitičkih virusnih lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/0-71067831.html Kako mali lijekovi nukleinske kiseline mogu promijeniti liječenje bolesti središnjeg živčanog sustava: Uvidi Prisys Biotechnology, pružatelja NHP modela bolesti https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71067834.html Farmakokinetika, strategije istraživanja i studije slučaja peptidnih lijekova https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69655437.html Ključne točke istraživanja lijeka ADC PK https://img01.v15cdn.com/gallery/4x3/148.webp https://hr.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69654547.html Prisys Biotechnology: Lider u istraživačkoj platformi za modeliranje bolesti središnjeg živčanog sustava NHP https://hr.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://hr.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309292.html Kako smršaviti i kontrolirati dijabetes s GLP-1 proizvodima https://hr.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://hr.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309401.html Kako kineski majmun pomaže u provedbi pretkliničke učinkovitosti istraživanja? https://hr.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://hr.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309353.html Koja je učinkovitost RNAi? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309354.html Platforma javne službe za pokuse na velikim životinjama Prisys Biotech: nisko{0}}cijenovno i visoko{1}}učinkovito rješenje za velike pokuse na životinjama https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69011347.html Kako AAV genska terapija može spasiti vaš vid: najnovija otkrića iz studija o primatima koji nisu-ljudi https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69010708.html Prisys Biotech predstavlja platformu modela ne{0}}ljudskih primata na godišnjem sastanku Japanskog društva za toksikologiju https://hr.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://hr.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69011678.html Obećavajuća budućnost AAV genske terapije kod primata koji nisu{0}}ljudi https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69011679.html Što su nanočestice lipida za gensku terapiju? https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69011037.html Prisys Biotech vas poziva da sudjelujete na 50. godišnjem sastanku Japanskog društva za toksikologiju (JSOT) https://hr.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://hr.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69011350.html Test imunotoksičnosti, procjena sigurnosti lijeka-PRISYS BIOTECH https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68305950.html Optimalni životinjski model ishemijskog moždanog udara utvrđen digitalnom suptrakcijskom angiografijom-vođenih autolognih tromba u Cynomolgus majmuna https://hr.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://hr.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68113929.html Zašto biste trebali brinuti o ne-ljudskim primatima u istraživanju i razvoju sustava za isporuku lijekova nukleinskih kiselina https://hr.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://hr.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68113931.html Upoznajte Prisys Biotech na 70. JALAS-u 2023! https://hr.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://hr.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68113930.html Genska terapija blista s novim odobrenjima za rijetke bolesti https://hr.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://hr.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68113928.html Revolucionarno otkriće lijekova: kako neljudski primati optimiziraju probir SiRNA za brže i učinkovitije rezultate https://hr.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://hr.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67546232.html Maksimiziranje farmakološke učinkovitosti SiRNA s istraživanjem primata koji nisu ljudi https://hr.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://hr.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67540621.html Kako neljudski primati mogu revolucionirati istraživanje SiRNA: Opsežan vodič https://hr.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://hr.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67542424.html Obilježavanje Svjetskog dana laboratorijskih životinja: zašto je Prisys predan promicanju zdravlja primata koji nisu ljudi https://hr.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://hr.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67543393.html Maksimiziranje učinkovitosti istraživanja CRISPR/Cas9 s modelima primata koji nisu ljudi https://hr.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://hr.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67541581.html Oslobađanje terapeutskog potencijala: zašto je ulaganje u lijekove nukleinske kiseline budućnost medicine https://hr.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://hr.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67540622.html Otključavanje potencijala neljudskih primata u poboljšanju otkrivanja ciljanih lijekova genske terapije https://hr.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://hr.prisysbiotech.com/news/world-parkinsons-disease-day-67547557.html Ujedinite se za Parkinsonovu bolest: udružimo ruke za podizanje svijesti na Svjetski dan Parkinsonove bolesti https://hr.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://hr.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67543394.html Kako učinkovito koristiti ne{0}}ljudske primate u procjeni sigurnosti genske terapije https://hr.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://hr.prisysbiotech.com/news/gene-therapy-toxicology-66273653.html Toksikološka istraživanja genske terapije s Nonhuam primatima https://hr.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://hr.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66124098.html Sveobuhvatni vodič za provođenje DMPK studije za gensku terapiju https://hr.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://hr.prisysbiotech.com/news/gene-therapy-nhp-model-66124082.html Revolucioniranje medicinskih istraživanja: otkrića genske terapije u modelima bolesti primata koji nisu ljudi! https://hr.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://hr.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66124087.html 10 najpopularnijih pitanja u vezi s genskom terapijom https://hr.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://hr.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66124084.html Prisys Biotech: Farmakologija ne-ljudskih primata za gensku terapiju https://hr.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://hr.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66124090.html Potpora ženskom zdravlju: pogled na endometriozu https://hr.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://hr.prisysbiotech.com/news/prisys-sot2023-66124078.html PRISYS i Taichu Group surađuju na izložbi SOT 2023 https://hr.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://hr.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66124080.html Trebamo li dodatne studije za procjenu boli? - NHP https://hr.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://hr.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66124079.html Pridružite nam se u obilježavanju Svjetskog dana divljih životinja https://hr.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://hr.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66124077.html Prisys Shanghai NHP R&D centar pokreće, obilježavajući prekretnicu u farmaceutskom istraživanju i razvoju u Kini https://hr.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://hr.prisysbiotech.com/news/meetprisys-sot2023-66124081.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://hr.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg